Elite Pharmaceuticals, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Elite Pharmaceuticals, Inc. (ELTP) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.21 per share for the 12-month period ending 2025-03-31, per its 10-K filed 2025-06-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-06-30
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-06-30 was $0.04, a 33.33% decline year-over-year.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2021-06-30 was $0.06.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2017-06-30 was $0.21.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.21, a 133.33% increase from fiscal 2024.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.09, a 200.00% increase from fiscal 2023.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $0.03, a 40.00% decline from fiscal 2022.
- Elite Pharmaceuticals, Inc. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $0.05, a 16.67% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.21 10-K · filed 2025-06-30 | |||
| 2024-12-31 | $0.21 10-Q · filed 2025-02-13 | |||
| 2024-03-31 | $0.09 10-K · filed 2024-07-01 | |||
| 2023-12-31 | $0.09 10-Q · filed 2024-02-14 | |||
| 2023-09-30 | $0.09 10-Q · filed 2023-11-14 | |||
| 2023-03-31 | $0.03 10-K · filed 2023-06-29 | |||
| 2022-12-31 | $0.04 10-Q · filed 2023-02-14 | |||
| 2022-09-30 | $0.04 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $0.04 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $0.05 10-K · filed 2023-06-29 | |||
| 2021-12-31 | $0.06 10-Q · filed 2022-02-14 | |||
| 2021-09-30 | $0.06 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $0.06 10-Q · filed 2021-08-16 | |||
| 2021-03-31 | $0.06 10-K · filed 2022-06-29 | |||
| 2020-03-31 | $0.10 10-K · filed 2021-06-14 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | |||
| 2018-03-31 | $0.16 10-K · filed 2019-06-21 | |||
| 2017-12-31 | $0.16 10-Q · filed 2018-02-09 | |||
| 2017-09-30 | $0.16 10-Q · filed 2017-11-09 | |||
| 2017-06-30 | $0.21 10-Q · filed 2017-08-09 | |||
| 2016-12-31 | $0.23 10-Q · filed 2017-02-09 | |||
| 2016-09-30 | $0.23 10-Q · filed 2016-11-09 | |||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $0.38 10-K · filed 2016-06-15 | |||
| 2015-03-31 | $0.31 10-K · filed 2016-06-15 | |||
| 2014-03-31 | $0.07 10-K · filed 2016-06-15 | |||
| 2013-03-31 | $0.12 10-K · filed 2014-06-30 | |||
| 2012-03-31 | $0.00 10-K · filed 2013-06-21 | |||
| 2010-03-31 | $0.10 10-K · filed 2014-06-30 |